So, Ojjaara/Omjjara sales amounted to $150 million in the fourth quarter of 2024, more than tripling year-on-year. While sales of the HIV therapy called Cabenuva also did not disappoint ...
New blood cancer drug Ojjaara/Omjjara generated £118 million in product sales compared with £98 million in third-quarter 2024. While the drug was approved by the FDA in September 2023 ...
GSK announced on Monday that Omjjara, its brand name for momelotinib, has been granted marketing authorisation by the European Commission, giving the company permission to market the drug and make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback